Abstract

BackgroundOxidative stress is a common cause of neurodegeneration and plays a central role in retinal degenerative diseases. Heme oxygenase-1 (HMOX1) is a redox-regulated enzyme that is induced in neurodegenerative diseases and acts against oxidative stress but can also promote cell death, a phenomenon that is still unexplained in molecular terms. Here, we test whether HMOX1 has opposing effects during retinal degeneration and investigate the molecular mechanisms behind its pro-apoptotic role.MethodsBasal and induced levels of HMOX1 in retinas are examined during light-induced retinal degeneration in mice. Light damage-independent HMOX1 induction at two different expression levels is achieved by intraocular injection of different doses of an adeno-associated virus vector expressing HMOX1. Activation of Müller glial cells, retinal morphology and photoreceptor cell death are examined using hematoxylin-eosin staining, TUNEL assays, immunostaining and retinal function are evaluated with electroretinograms. Downstream gene expression of HMOX1 is analyzed by RNA-seq, qPCR examination and western blotting. The role of one of these genes, the pro-apoptotic DNA damage inducible transcript 3 (Ddit3), is analyzed in a line of knockout mice.ResultsLight-induced retinal degeneration leads to photoreceptor degeneration and concomitant HMOX1 induction. HMOX1 expression at low levels before light exposure prevents photoreceptor degeneration but expression at high levels directly induces photoreceptor degeneration even without light stress. Photoreceptor degeneration following high level expression of HMOX1 is associated with a mislocalization of rhodopsin in photoreceptors and an increase in the expression of DDIT3. Genetic deletion of Ddit3 in knockout mice prevents photoreceptor cell degeneration normally resulting from high level HMOX1 expression.ConclusionThe results reveal that the expression levels determine whether HMOX1 is protective or deleterious in the retina. Furthermore, in contrast to the protective low dose of HMOX1, the deleterious high dose is associated with induction of DDIT3 and endoplasmic reticulum stress as manifested, for instance, in rhodopsin mislocalization. Hence, future applications of HMOX1 or its regulated targets in gene therapy approaches should carefully consider expression levels in order to avoid potentially devastating effects.

Highlights

  • Oxidative stress is a common cause of neurodegeneration and plays a central role in retinal degenerative diseases

  • Immunohistochemistry showed that rhodopsin was normally localized in the outer segment layer of the retina but with increasing duration of light exposure was gradually mislocalized to the outer nuclear layer (ONL) (Fig. 1b)

  • Q-room temperature (RT)-PCR and WB data consistently showed that Heme oxygenase-1 (Hmox1) RNA expression was upregulated in retinas after Light damage (LD) and that the levels of Heme oxygenase-1 (HMOX1) protein increased with the duration of light exposure (Fig. 1c and d)

Read more

Summary

Introduction

Oxidative stress is a common cause of neurodegeneration and plays a central role in retinal degenerative diseases. General antioxidant treatment may be an appropriate approach to prevent retinal degeneration, but serious side effects have so far hindered success in clinical trials. It is paramount, to explore in more detail the oxidative stress pathway during retinal degeneration in order to identify more specific therapeutic targets. Its catalyzed metabolites, such as CO and biliverdin, are able to exert strong antioxidant, antiapoptotic and anti-inflammatory activities [9, 10] In both human and mouse, germline genetic deficiencies of Hmox render multiple tissues vulnerable to oxidative stress [11,12,13] and experimental overexpression of Hmox in mouse astrocytes attenuates neuronal cell death caused by oxidative stress [14]. HMOX1 induction is recognized as an endogenous protective system to prevent oxidative injury in the nervous system

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call